Skip to main content

National Treatment Agency

Volume 460: debated on Tuesday 22 May 2007

One GP sits on the board. His full-time job is director of public health for the south-west but he brings his knowledge and experience to the board. A GP in the National Treatment Agency for Substance Misuse clinical team liaises with the Royal College of General Practitioners and others to support effective delivery of policy and promotion of good practice within the primary care setting.

The evidence from Sweden and France, as examined by my primary care trust, is unequivocal. Drug treatment is far more effective if primary care and GPs are put at the centre of it. Is it not time that we move towards having a bigger GP presence on the NTA so that primary care is in the mainstream of drug treatment in this country?

I congratulate my hon. Friend on the work he has done in his area to achieve direct access to drug treatment services through GPs in the primary care setting. The “Bassetlaw Direct Access” drugs service has had tremendous results, with an 83 per cent. retention rate. I agree with my hon. Friend that GPs’ experiences should be represented. However, we are also trying to make sure that we embed substance misuse as an issue in the medical colleges; on 30 April we published curriculum guidelines on substance misuse. We are also improving the opportunities for GP practices to provide access to drug treatment, particularly in rural and semi-rural areas. However, we will endeavour to do more.

Is the Minister aware that the NTA values the contribution that GPs make in working with drug addicts and saving lives? However, how many GPs have been struck off by the General Medical Council for over-prescribing?

I will have to get back to the hon. Gentleman on that specific point, but the most recent figures—those for 2004-05—show that the number of GPs participating in shared care schemes for providing treatment to drug users has increased in the last 10 years from 20 per cent. to 32 per cent. Clearly we need to do more, but that is a good sign. We must embed the culture of understanding drug treatment in the earliest days of training. That is why providing the guidance to the medical colleges on 30 April was an investment in the future. I hope that more GPs will see this as one of the health roles that they should play in their communities.